Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum

Journal of Neurochemistry

Volumn 72, Issue 1, 1999, Pages 148-156

  Dickinson, Shelly D ^a   Sabeti, Jilla ^a   Larson, Gaynor A ^a   Giardina, Karen ^a   Rubinstein, Marcelo ^c   Kelly, Michele A ^b   Grandy, David K ^b   Low, Malcolm J ^b   Gerhardt, Greg A ^a   Zahniser, Nancy R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

D2 dopamine autoreceptor; Dopamine uptake; Gene knockout mice; In vivo electrochemistry; In vivo microdialysis; Striatum

Indexed keywords

DOPAMINE 2 RECEPTOR; (1R (EXO,EXO)) 3 (4 FLUOROPHENYL) 8 METHYL 8 AZABICYCLO(3.2.1)OCTANE 2 CARBOXYLIC ACID, METHYL ESTER; (1R-(EXO,EXO))-3-(4-FLUOROPHENYL)-8-METHYL-8- AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, METHYL ESTER; 3,4 DIHYDROXYPHENYLACETIC ACID; AUTORECEPTOR; CARRIER PROTEIN; COCAINE; DIAGNOSTIC AGENT; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; DOPAMINE UPTAKE INHIBITOR; DRUG DERIVATIVE; HOMOVANILLIC ACID; MEMBRANE PROTEIN; NERVE PROTEIN; RACLOPRIDE; SALICYLAMIDE DERIVATIVE; SLC6A3 PROTEIN, MOUSE; TRITIUM;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; FEMALE; KNOCKOUT MOUSE; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; ANIMAL; BRAIN LEVEL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR SPACE; GENETICS; METABOLISM; MICRODIALYSIS; MOUSE MUTANT; PHYSIOLOGY; RADIOASSAY;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; AUTORECEPTORS; BRAIN CHEMISTRY; CARRIER PROTEINS; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; EXTRACELLULAR SPACE; FEMALE; HOMOVANILLIC ACID; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, KNOCKOUT; MICRODIALYSIS; NERVE TISSUE PROTEINS; RACLOPRIDE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; TRITIUM;

EID: 0032589784     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720148.x     Document Type: Article

References (42)

1. Altar C. A., Boyar W. C., and Wood P. L. (1987) Dopamine autoreceptor agonists including CGS 15855A decrease dopamine release and metabolism in mouse brain. Eur. J. Pharmacol. 134, 303-311.
2. 2 receptors. Nature 377, 424-428.
3. Bohmaker K., Puza T., Goldstein M., and Meller E. (1989) Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum. J. Pharmacol. Exp. Ther. 248, 97-103.
4. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6, 3177-3188.
5. 2 dopamine receptors can modulate dopamine uptake. Neurosci. Lett. 176, 259-263.
6. Chiodo L. A. and Bunney B. S. (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J. Neurosci. 8, 1607-1619.
7. 3H]mazindol binding but not striosome/ matrix. Exp. Neurol. 134, 135-149.
8. 2 dopamine receptors. J. Pharmacol. Exp. Ther. 239, 442-453.
9. Fleckenstein A. E., Metzger R. R., Beyeler M. L., Gibb J. W., and Hanson G. R. (1997) Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334, 111-114.
10. Franklin K. B. F. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego.
11. Friedemann M. N. and Gerhardt G. A. (1992) Regional effects of aging on dopaminergic function in the Fischer 344 rat. Neurobiol. Aging 13, 325-332.
12. Giros B., Jaber M., Jones S. R., Wightman R. M., and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
13. Gratton A., Hoffer B. J., and Gerhardt G. A. (1989) In vivo electrochemical studies of monoamine release in the medial prefrontal cortex of the rat. Neuroscience 29, 57-64.
14. Graybiel A. M. and Moratalla R. (1989) Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc. Natl. Acad. Sci. USA 75, 5723-5727.
15. Heben M. and Gerhardt G. A. (1997) Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J. Pharmacol. Exp. Ther. 282, 760-768.
16. Hoffman A. F., van Horne C. G., Eken S., Hoffer B. J., and Gerhardt G. A. (1997) In vivo microdialysis studies of somatodendritic dopamine release in rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF. Exp. Neurol. 147, 130-141.
17. Imperato A. and Di Chiara G. (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by transstriatal dialysis. J. Neurosci. 5, 297-306.
18. 2 receptor-deficient mice. Neuron 19, 103-113.
19. 2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosci. 18, 3470-3479.
20. 3 receptor mutant mice. J. Neurosci. 18, 2231-2238.
21. 2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. J. Physiol. (Lond.) 392, 397-416.
22. Langer S. Z. (1997) 25 years since the discovery of the presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol. Sci. 18, 95-99.
23. L'hirondel M., Cheramy A., Godeheu G., Artaud F., Saiardi A., Borrelli E., and Glowinski J. (1998) Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice. Brain Res. 792, 253-262.
24. 2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764-767.
25. Meller E., Enz A., and Goldstein M. (1988) Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity. Eur. J. Pharmacol. 155, 151-154.
26. 2 receptor deficient mice. Neuroscience 79, 323-327.
27. 2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J. Neurochem. 60, 376-379.
28. 3H]dopamine uptake. Brain Res. 641, 83-91.
29. 3H]tropane to the dopamine uptake carrier. J. Neurochem. 61, 167-177.
30. Reith M. E. A., Xu C., and Chen N. H. (1997) Pharmacology and regulation of the neuronal dopamine transporter. Eur. J. Pharmacol. 324, 1-10.
31. 2 receptors. Adv. Pharmacol. 42, 521-524.
32. 2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J. Neurosci. 14, 88-106.
33. Sokoloff P. and Schwartz J.-C. (1995) Novel dopamine receptors half a decade later. Trends Pharmacol Sci. 16, 270-275.
34. Sonders M. S., Zhu S. J., Zahniser N. R., Kavanaugh M. P., and Amara S. G. (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J. Neurosci. 17, 960-974.
35. 3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270, 475-479.
36. 3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neurosci. 17, 2519-2530.
37. Westerink B. H. C. and de Vries J. B. (1989) On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals. Neurosci. Lett. 99, 197-202.
38. 3H]dopamine. Eur. J. Pharmacol. 155, 323-327.
39. Zahniser N. R., Gerhardt G. A., and Cass W. A. (1995) Chronic cocaine action on the dopamine transporter, in The Neurobiology of Cocaine: Cellular and Molecular Mechanisms (Hammer R. P. Jr., ed), pp. 181-197. CRC Press, Boca Raton, Florida.
40. Zahniser N. R., Gerhardt G. A., Hoffman A. F., and Lupica C. R. (1998) Voltage-dependency of the dopamine transporter in rat brain. Adv. Pharmacol. 42, 195-198.
41. Zetterström T., Sharp T., Collin A. K., and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327-334.
42. Zhu S. J., Kavanaugh M. P., Sonders M. S., Amara S. G., and Zahniser N. R. (1997) Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 282, 1358-1365.